Company: MBIO
Filing Date: 2025-04-01
Form Type: 424B3
Source: 0001104659-25-030657
Chunk: 90

Company: MUSTANG BIO, INC.
Filing Date: 2025-04-01
Form: 424B3
Chunk 90
---
 trade secrets and unpatented
know-how, including entering into confidentiality and non-use agreements with third parties, and proprietary information and invention
assignment agreements with employees, consultants and advisers, third parties may still come upon this same or similar information independently.
Despite these efforts, any of these parties may also breach the agreements and may unintentionally or willfully disclose our or our licensors’
proprietary information, including our trade secrets, and we may not be able to identify such breaches or obtain adequate remedies. Enforcing
a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome
is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to protect trade secrets.
Moreover, if any of our or our licensors’ trade secrets were to be lawfully obtained or independently developed by a competitor,
we and our licensors would have no right to prevent them, or those to whom they communicate it, from using that technology or information
to compete with us. If any of our or our licensors’ trade secrets were to be disclosed to or independently developed by a competitor,
our competitive positions would be harmed.

The patent prosecution process is expensive and
time-consuming, and we may not be able to file and prosecute all necessary or desirable patent applications at a reasonable cost or in
a timely manner. It is also possible that we will fail to identify any patentable aspects of our research and development output and methodology,
and, even if we do, an opportunity to obtain patent protection may have passed. Given the uncertain and time-consuming process of filing
patent applications and prosecuting them, it is possible that our product(s) or process(es) originally covered by the scope of the
patent application may have changed or been modified, leaving our product(s) or process(es) without patent protection. If our licensors
or we fail to obtain or maintain patent protection or trade secret protection for one or more product candidates or any future product
candidate we may license or acquire, third parties may be able to leverage our proprietary information and products without risk of infringement,
which could impair our ability to compete in the market and adversely affect our ability to generate revenues and achieve profitability.
Moreover, should we enter into other collaborations we may be required to consult with or cede control to collaborators regarding the
prosecution, maintenance and enforcement of licensed patents. Therefore, these patents and applications may not be prosecuted and enforced
in a manner consistent with the best interests of our business.